Mani, Inc.TSE: 7730

Notice Regarding Completion of Interim Review by Certified Public Accountants, etc. of the Japanese-Language Originals of the “Consolidated Financial Results for the Three Months Ended November 30, 2024 (Based on Japanese GAAP)”

· Issued by Mani, Inc.

January 14, 2025

Company Name: MANI, INC.

Representative: Masaya Watanabe

Director, President & Representative

Executive Officer

Security Code: 7730, Prime Market of TSE

Inquiries: Naohisa Hashimoto

Managing Executive Officer, CFO

TEL: +81 28-667-1811

Notice Regarding Completion of Interim Review by Certified Public Accountants, etc. of the Japanese-Language Originals of the "Consolidated Financial Results for the Three Months Ended November 30, 2024 (Based on Japanese GAAP)"

MANI, INC. (the "Company") hereby announces that the interim review of the Japanese-language originals of the "Consolidated Financial Results for the Three Months Ended November 30, 2024 (Based on Japanese GAAP)" disclosed on January 8, 2025 have been completed by certified public accountants, etc.

There are no revisions made to the quarterly consolidated financial statements disclosed on January 8, 2025.

Note that the English translation of the quarterly consolidated financial results did not receive a quarterly review by certified public accountants, etc.

Summary of Consolidated Financial Results for the Three Months Ended November 30, 2024 (Based on Japanese GAAP)

January 14, 2025

Company name:

MANI, INC.

Stock exchange listing:

Tokyo

Stock code:

7730

URL https://www.mani.co.jp/en/

Representative:

Director, President & Representative Executive Officer

Masaya Watanabe

Inquiries:

Managing Executive Officer, CFO

Naohisa Hashimoto

TEL +81 28-667-1811

Scheduled date to commence dividend payments:

-

Preparation of supplementary material on financial results:

Yes

Holding of financial results meeting:

Yes

(Presentation on management policy held on January

9, 2025)

(Amounts less than one million yen are rounded down)

1. Consolidated Financial Results for the Three Months Ended November 30, 2024 (from September 1, 2024 to November 30, 2024)

(1) Consolidated Operating Results (cumulative)

(Percentages indicate year-on-year changes)

Net Sales

Operating income

Ordinary income

Profit attributable to

owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Three months ended November 30, 2024

7,655

7.6

2,107

(5.2)

2,298

(2.2)

1,598

1.6

Three months ended November 30, 2023

7,114

16.5

2,223

27.1

2,349

35.4

1,573

21.1

Note:

Comprehensive income:

For the three months ended November 30, 2024

¥2,280 million

[31.4%]

For the three months ended November 30, 2023

¥1,735 million

[28.7%]

Earnings per share

Diluted earnings per share

Yen

Yen

Three months ended November 30, 2024

16.23

-

Three months ended November 30, 2023

15.98

-

(2) Consolidated Financial Position

Total assets

Net assets

Equity capital ratio

Millions of yen

Millions of yen

%

As of November 30, 2024

57,334

52,345

91.3

As of August 31, 2024

57,177

52,330

91.5

Reference:

Equity

As of November 30, 2024

¥52,345 million

As of August 31, 2024

¥52,330 million

2. Cash Dividends

Annual dividends per share

1Q-end

2Q-end

3Q-end

Year-end

Total

Yen

Yen

Yen

Yen

Yen

Year ended August 31, 2024

-

16.00

-

23.00

39.00

Year ending August 31, 2025

-

Year ending August 31, 2025 (Forecast)

16.00

-

23.00

39.00

Note:

Revisions to the forecasts of dividends most recently announced: None

3. Forecast of Consolidated Financial Results for the Fiscal Year Ending August 31, 2025 (from September 1, 2024 to August 31, 2025) (Percentages indicate year-on-year changes)

Net Sales

Operating income

Ordinary income

Profit attributable to

Earnings per share

owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Second quarter

14,750

6.1

4,200

0.1

4,200

(7.7)

3,000

(6.0)

30.45

Full year

30,200

5.9

8,900

6.1

8,850

4.6

6,350

1.0

64.45

Note:

Revisions to

earnings forecasts most recently announced: None

  • Notes
  1. Significant changes in the scope of consolidation during the period: None
    Newly included: -
    Excluded: -
  2. Application of special accounting methods in the preparation of quarterly consolidated financial statements: None
  3. Changes in accounting policies, changes in accounting estimates, and restatement

① Changes in accounting policies due to revisions to accounting standards and other regulations:

None

②Changes in accounting policies due to other reasons:

None

③Changes in accounting estimates:

None

④Restatement:

None

(4) Number of issued shares (common shares)

① Total number of issued shares at the end of the period (including treasury shares)

As of November 30, 2024

107,003,277 shares

As of August 31, 2024

107,003,277 shares

②Number of treasury shares at the end of the period

As of November 30, 2024

8,517,206 shares

As of August 31, 2024

8,484,606 shares

③Average number of shares during the period (cumulative from the beginning of the fiscal year)

As of November 30, 2024

98,488,661 shares

As of November 30, 2023

98,496,979 shares

Disclosure regarding quarterly review procedures

Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: Yes (voluntary)

  • The English translation of the quarterly consolidated financial results will not receive a quarterly review by certified public accountants or an audit firm.

Proper use of earnings forecasts, and other special matters

  • The forward-looking statements, including earnings forecasts, contained in these materials are based on information currently available to the Company and on certain assumptions deemed to be reasonable. Consequently, any statements herein do not constitute assurances regarding actual results by the Company. Actual business and other results may differ substantially due to various factors.
  • This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

MANI, INC. (TOKYO 7730) Consolidated Financial Results of the First Quarter of the Fiscal Year Ending August 31, 2025

  • Attached Materials Index

1. Overview of Operating Results

2

(1)

Explanation of Operating Results for the First Quarter

2

(2)

Explanation of Financial Position for the First Quarter

3

(3)

Explanation of Future Forecast Information including Consolidated Business Results Forecasts

4

2. Quarterly Consolidated Financial Statements

5

(1)

Quarterly Consolidated Balance Sheet

5

(2)

Quarterly Consolidated Income Statements and Quarterly Consolidated Comprehensive Income Statements

7

Quarterly Consolidated Income Statements

For the three months ended November 30, 2023 and November 30, 2024

7

Quarterly Consolidated Comprehensive Income Statements

For the three months ended November 30, 2023 and November 30, 2024

8

3. Notes to Quarterly Consolidated Financial Statements

9

(Notes on Premise of Going Concern)

9

(Notes on Significant Changes in the Amounts of Shareholders' Equity)

9

(Notes on Quarterly Consolidated Statements of Cash Flows)

9

(Segment Information, etc.)

9

(Revenue Recognition)

10

(Significant Subsequent Events)

10

- 1 -

MANI, INC. (TOKYO 7730) Consolidated Financial Results of the First Quarter of the Fiscal Year Ending August 31, 2025

1. Overview of Operating Results

(1) Explanation of Operating Results for the First Quarter

MANI Group aims to contribute to the well-being of people around the world by providing our products worldwide, based on our commitment "The Best Quality in the World, to the World." To achieve further growth, we have started our medium-term management plan from the fiscal year ended August 31, 2022, and are engaged in realizing our corporate philosophy and evolve to "a true global company" by dramatically evolving and transforming our platforms in sales, production, and development functions.

The following is a summary of major initiatives during the first quarter of the fiscal year ending August 31, 2025.

Business Operations under a New Organizational Structure

A new management team led by Masaya Watanabe, President and Representative Executive Officer, has begun business operations. Please refer to the material scheduled to be released on January 9, 2025 for our progress of the medium-term management plan announced on April 8, 2021 and future management policies.

Established sales subsidiary MANI MEDICAL AMERICA, INC. in California, United States

To expand our business globally, we established a new sales subsidiary, MANI MEDICAL AMERICA, INC., in September 2024, and commenced sales activities. We will promote regional-oriented sales activities in medical advanced countries and expand our business in the North American market.

Launch of the new NiTi Rotary File "JIZAI 020 04"

In September 2024, we launched "JIZAI 020 04," which is a new addition to the "JIZAI"1 series, a series of NiTi rotary files for dental root canal treatment and is designated as a key development product to be developed in the medium-term management plan. "JIZAI 020 04" is an intermediate sized file that has been particularly requested by many dentists, and we have developed this file to encourage more dentists to use "JIZAI." Going forward, we will expand our product lineup of NiTi rotary files to accommodate a range of root canal treatments and expand the scope of treatments available with our products.

The Smart Factory

The Smart Factory, which began construction in Japan in October 2023, is scheduled to be completed at the end of January 2025. During the first quarter of the fiscal year ending August 31, 2025, we have been preparing to build a mass production system for ophthalmic knives, which are used in cataract surgery, and "JIZAI," the NiTi rotary file. The mass production line is scheduled to start operation from 2026.

(References)

1 A flexible nickel titanium dental endodontic instrument used to treat an infected dental root canal in an endodontic treatment, which is one of the treatments for the dental nervous system known as pulp.

Operating Results for the First Quarter of the Fiscal Year Ending August 31, 2025

Net sales were ¥7,655 million (up 7.6% year on year), mainly due to strong sales of Surgical products in Europe and an increase in sales of Eyeless Needle products in Asia, particularly in China, despite a decrease in sales of Dental products in China. The cost of sales was ¥2,653 million (down 0.5% year on year), and the selling, general and administrative expenses were ¥2,893 million (up 30.1% year on year) due to the posting of bonuses associated with the results of the previous fiscal year and an increase in personnel costs. As a result, operating income was ¥2,107 million (down 5.2% year on year). Though ordinary income was ¥2,298 million (down 2.2% year on year), profit attributable to owners of parent was ¥1,598 million (up 1.6% year on year) due to a decrease in income taxes-deferred.

The following is an overview of financial results by segment. Segment sales figures are those from external customers.

Net sales

Segment income (Operating income)

Millions of yen

Year on year

Millions of yen

Year on year

Surgical products

2,442

25.5%

838

28.8%

Eyeless Needle products

2,844

12.9%

1,046

8.2%

Dental products

2,368

(10.6%)

222

(63.2%)

Consolidated total

7,655

7.6%

2,107

(5.2%)

- 2 -

MANI, INC. (TOKYO 7730) Consolidated Financial Results of the First Quarter of the Fiscal Year Ending August 31, 2025

(Surgical products)

The segment sales were ¥2,442 million (up 25.5% year on year) and segment income was ¥838 million (up 28.8% year on year). Segment sales and income have increased due to an increase in demand for ophthalmic knives, which are used in cataract surgery, mainly in Europe and Asia, particularly in China from the same period of the previous fiscal year.

(Eyeless Needle products)

The segment sales were ¥2,844 million (up 12.9% year on year) and segment income was ¥1,046 million (up 8.2% year on year). Segment sales and income have increased from the same period of the previous fiscal year, mainly due to an increase in sales in Asia, particularly in China.

(Dental products)

The segment sales were ¥2,368 million (down 10.6% year on year), and segment income was ¥222 million (down 63.2% year on year). Sales declined due to the deterioration in the dental market caused by the stagnant Chinese economy, the impact of the voluntary recall of dental rotary and cutting instruments (dia-burs), and changes in procedures in dental root canal treatment.

Segment income has decreased due to a decrease in net sales and an increase in selling, general and administrative expenses, including personnel expenses.

※Reference: Exchange rates

Previous consolidated accounting period

Current consolidated accounting period

(Year ended August 31, 2024)

(Year ending August 31, 2025)

1Q

2Q

3Q

4Q

1Q

2Q

3Q

4Q

USD/JPY

149.10

147.92

149.66

150.78

149.03

-

-

-

EUR/JPY

159.30

159.38

161.40

162.94

161.99

-

-

-

CNY/JPY

20.47

20.45

20.68

20.84

20.88

-

-

-

INR/JPY

1.79

1.78

1.80

1.81

1.77

-

-

-

MYR/JPY

31.95

31.35

31.78

32.28

34.36

-

-

-

  1. Explanation of Financial Position for the First Quarter Financial position

(Millions of yen)

As of August 31, 2024

As of November 30, 2024

Change

Total assets

57,177

57,334

157

Current assets

31,942

32,122

179

Non-current assets

25,235

25,212

(22)

Liabilities

4,846

4,989

142

Net assets

52,330

52,345

14

Total assets as of the end of the first quarter (November 30, 2024) stood at ¥57,334 million, an increase of ¥157 million from the end of the previous consolidated accounting period. This was primarily due to an increase of ¥179 million in current assets (mainly an increase in inventories).

Total liabilities as of the end of the first quarter (November 30, 2024) stood at ¥4,989 million, an increase of ¥142 million from the end of the previous consolidated accounting period. This was primarily due to an increase in current liabilities such as accrued expenses and accounts payable, despite a decrease in income taxes payable.

Total net assets as of the end of the first quarter (November 30, 2024) stood at ¥52,345 million, an increase of ¥14 million from the end of the previous consolidated accounting period. This was primarily due to an increase of ¥1,598 million in retained earnings resulting from the recording of profit attributable to owners of parent and an increase in foreign currency translation adjustments, despite a decrease in retained earnings due to the payment of cash dividends of ¥2,265 million.

- 3 -

MANI, INC. (TOKYO 7730) Consolidated Financial Results of the First Quarter of the Fiscal Year Ending August 31, 2025

(3) Explanation of Future Forecast Information including Consolidated Business Results Forecasts

Results for the first quarter of the fiscal year ending August 31, 2025, are as stated in "(1) Explanation of Operating Results for the First Quarter." The consolidated earnings forecast for the full fiscal year remains unchanged from the figures announced in the "Summary of Consolidated Financial Results for the Fiscal Year Ended August 31, 2024" on October 7, 2024.

- 4 -

MANI, INC. (TOKYO 7730) Consolidated Financial Results of the First Quarter of the Fiscal Year Ending August 31, 2025

2. Quarterly Consolidated Financial Statements

  1. Quarterly Consolidated Balance Sheet

(Millions of yen)

As of August 31, 2024

As of November 30, 2024

Assets

Current assets

Cash and deposits

21,644

21,214

Notes receivable - trade

210

131

Accounts receivable - trade

2,710

2,931

Securities

18

314

Merchandise and finished goods

896

856

Work in process

3,244

3,469

Raw materials and supplies

2,221

2,292

Other

1,009

926

Allowance for doubtful accounts

(14)

(14)

Total current assets

31,942

32,122

Non-current assets

Property, plant and equipment

Buildings and structures, net

6,779

6,789

Machinery, equipment and vehicles, net

4,456

4,611

Land

4,427

4,423

Construction in progress

6,290

6,550

Other, net

714

718

Total property, plant and equipment

22,669

23,093

Intangible assets

Software

642

663

Other

696

661

Total intangible assets

1,338

1,324

Investments and other assets

Investment securities

303

45

Deferred tax assets

593

424

Insurance funds

214

214

Other

116

110

Allowance for doubtful accounts

(0)

(0)

Total investments and other assets

1,228

794

Total non-current assets

25,235

25,212

Total assets

57,177

57,334

- 5 -

MANI, INC. (TOKYO 7730) Consolidated Financial Results of the First Quarter of the Fiscal Year Ending August 31, 2025

(Millions of yen)

As of August 31, 2024

As of November 30, 2024

Liabilities

Current liabilities

Accounts payable - trade

181

215

Accounts payable - other

1,153

1,355

Lease liabilities

39

38

Income taxes payable

996

533

Provision for bonuses

401

308

Other

1,139

1,593

Total current liabilities

3,912

4,043

Non-current liabilities

Lease liabilities

44

36

Retirement benefit liability

583

590

Asset retirement obligations

233

245

Other

73

72

Total non-current liabilities

934

945

Total liabilities

4,846

4,989

Net assets

Shareholders' equity

Share capital

1,087

1,087

Capital surplus

1,134

1,134

Retained earnings

48,124

47,456

Treasury shares

(3,125)

(3,125)

Total shareholders' equity

47,220

46,552

Accumulated other comprehensive income

Valuation difference on available-for-sale

11

9

securities

Foreign currency translation adjustment

5,057

5,739

Remeasurements of defined benefit plans

42

43

Total accumulated other comprehensive income

5,110

5,792

Total net assets

52,330

52,345

Total liabilities and net assets

57,177

57,334

- 6 -

MANI, INC. (TOKYO 7730) Consolidated Financial Results of the First Quarter of the Fiscal Year Ending August 31, 2025

  1. Quarterly Consolidated Income Statements and Quarterly Consolidated Comprehensive Income Statements (Quarterly Consolidated Income Statements)

(For the three months ended November 30, 2023 and November 30, 2024)

(Millions of yen)

Three months ended

Three months ended

November 30, 2023

November 30, 2024

Net sales

7,114

7,655

Cost of sales

2,667

2,653

Gross profit

4,447

5,001

Selling, general and administrative expenses

2,224

2,893

Operating profit

2,223

2,107

Non-operating income

Interest income

32

33

Foreign exchange gains

88

144

Gain on sale of scraps

9

18

Other

5

12

Total non-operating income

135

209

Non-operating expenses

Interest expenses

0

1

Unoperated land-related costs

8

14

Other

0

2

Total non-operating expenses

9

18

Ordinary profit

2,349

2,298

Extraordinary income

Gain on sale of non-current assets

0

12

Total extraordinary income

0

12

Extraordinary losses

Loss on sale of non-current assets

-

0

Loss on retirement of non-current assets

3

0

Other

-

3

Total extraordinary losses

3

4

Profit before income taxes

2,347

2,306

Income taxes - current

561

538

Income taxes - deferred

211

169

Total income taxes

773

708

Profit

1,573

1,598

Profit attributable to owners of parent

1,573

1,598

- 7 -

Company analysis